Cognitive function and the emotional state of stroke patients on antihypertensive therapy

被引：3

作者：

Starchina Yu.A. ^{[1
]}

Parfenov V.A. ^{[1
]}

Chazova I.E. ^{[1
]}

Sinitsyn V.E. ^{[1
]}

Pustovitova T.S. ^{[1
]}

Kolos I.P. ^{[1
]}

Ustyuzhanin D.V. ^{[1
]}

机构：

[1] I. M. Sechenov Moscow Medical Academy, Russian Cardiological Scientific-Industrial Complex, Ministry of Health of the Russian Federation, Moscow

来源：

Neuroscience and Behavioral Physiology | 2007年 / 37卷 / 1期

关键词：

Antihypertensive therapy; Arterial hypertension; Cognitive impairments; Emotional impairments; Prophylaxis; Recurrent stroke;

D O I：

10.1007/s11055-007-0143-z

中图分类号：

学科分类号：

摘要：

Combined antihypertensive therapy based on 2.5-5 mg of cilazapril (an angiotensin-converting enzyme inhibitor) to normalize arterial pressure (ABP) was studied in 22 patients (12 male, 10 female) aged 49-74 years (mean 63 ± 7 years) with stroke (18 patients) or transient ischemic attacks (three patients). Magnetic resonance tomography (MRT) including perfusion studies, along with neuropsychological studies and assessment of emotional status (Beck depression inventory, Spielberger anxiety scale), were performed before and after treatment. After six months of treatment, patients showed normalization of ABP (systolic pressure decreased from 154.7 ± 12 to 128 ± 23 mmHg, diastolic from 90.3 ± 9.6 to 79.4 ± 23 mmHg). There were no side effects and no patient experienced stroke. MRT revealed no signs of new foci and there were no significant changes in brain blood flow. By the end of treatment, improvements in cognitive functions were noted on the Mini Mental State Examination, the 10-word memory test, the Boston naming test, or the Wisconsin card-sorting test, though there were no changes in the patients' emotional status. © Springer Science+Business Media, Inc. 2007.

引用

页码：13 / 17

页数：4

共 25 条

[1]

Barba R., Martinez-Espinozo S., Rodriguez-Garcia E., Et al., Poststroke dementia, Stroke, 31, 7, (2003)

[2]

Gorelick P.B., Brody G., Cohen D., Et al., Risk factors for dementia associated with multiple cerebral infarcts: A case-control analysis in predominantly African-American hospital-based patients, Arch. Neurol., 50, pp. 714-720, (1993)

[3]

Tatemichi T.K., Foulkes M.A., Mohr J.J., Et al., Dementia in stroke survivors in the Stroke Data Bank cohort: Prevalence, incidence, risk factors, and computed tomographic findings, Stroke, 21, pp. 858-866, (1990)

[4]

Pohjasvaara T., Erkinjuntti T., Yulikoski R., Et al., Clinical determinants of poststroke dementia, Stroke, 29, pp. 75-81, (1998)

[5]

Tatemichi T.K., Desmond D.W., Mayeuz R., Et al., Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort, Neurology, 42, pp. 1185-1193, (1992)

[6]

Loeb C., Gandolfo C., Croce R., Conti M., Dementia associated with lacunar infarction, Stroke, 23, pp. 1225-1229, (1992)

[7]

Robinson R.G., Starkstein S.E., Current research in affective disorders following stroke, J. Neuropsych. Clin. Neurosci., 2, 1, pp. 1-14, (1990)

[8]

Andersen G., Et al., Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor citalopram, Stroke, 25, pp. 1099-1104, (1994)

[9]

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack, Lancet, 358, pp. 1033-1041, (2001)

[10]

Bosch J., Yusuf S., Pogue J., Et al., Use of ramipril in preventing stroke: Double blind randomised trial, Brit. Med. J., 324, pp. 699-702, (2002)

← 1 2 3 →